Return and Destruction of Supplies in Clinical Trials: Complete Compliance Guide
After the conclusion of patient participation or trial phases, unused, expired, or damaged investigational products and associated supplies must be retrieved, reconciled, and destroyed in accordance with Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and local regulations. Mishandling returns or destruction can result in regulatory sanctions, data questioning, or environmental violations.
Click to read the full article.